The Tokyo, Japan BioPharma Exhibition is the largest biopharmaceutical technology exhibition in Japan. It covers research and development technologies, manufacturing technologies, and contract services. Visitors, exhibitors, and related personnel from the biopharmaceutical technology field worldwide.

Japan has become the world's second-largest R&D investment country in the biopharmaceutical industry, ranking third in the world after the United States and China in terms of the scale of investment in the pharmaceutical and biotechnology industries. The global biopharmaceutical industry is developing rapidly.

The Tokyo, Japan BioPharma Exhibition had an exhibition area of 26,000 square meters last session, with 515 participating companies from China, South Korea, Dubai, Russia, the United States, Mexico, Singapore, the UK, France, etc., and the number of participants reached 43,000 people.

In recent years, as the trend of population aging in Japan increases, the demand for related industries in the country is also increasing year by year. At the same time, the Japanese government is actively promoting pharmaceutical market innovation policies, which require strong support from the international market to introduce new technologies and resources, especially in new drug testing and development, stem cell regenerative medicine, and standardized practical applications of cell therapies, and safety testing of new drugs.

The Tokyo, Japan BioPharma Exhibition (BioPharma Expo) brings unlimited business opportunities to merchants from all over the world. (The content of this article belongs exclusively to Juzhan Network. Unauthorized reproduction is prohibited.)